抽象的
Eosinopenia as a Diagnostic Marker in Covid-19?
Francis Ajeneye, Oladimeji Olofin
Eosinopenia is defined as a decrease of circulating eosinophils<0.01 × 109/l. Eosinopenia is mediated by adrenalglucocorticosteroids and epinephrine in acute stress, whereas inacute inflammatory states, this is not reliant upon the endocrinemechanisms. The use of eosinopenia as a marker is aencouraging observation in COVID-19 infection, besidesrequire further investigation
免责声明: 此摘要通过人工智能工具翻译，尚未经过审核或验证。